{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:13:50Z","timestamp":1776269630419,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK085689"],"award-info":[{"award-number":["U01 DK085689"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL153178"],"award-info":[{"award-number":["R01 HL153178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK093770"],"award-info":[{"award-number":["R01DK093770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL085757"],"award-info":[{"award-number":["R01HL085757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DK106962"],"award-info":[{"award-number":["U01DK106962"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3DK114866"],"award-info":[{"award-number":["UH3DK114866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92022D00001"],"award-info":[{"award-number":["75N92022D00001"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92022D00002"],"award-info":[{"award-number":["75N92022D00002"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92022D00003"],"award-info":[{"award-number":["75N92022D00003"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92022D00004"],"award-info":[{"award-number":["75N92022D00004"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["75N92022D00005"],"award-info":[{"award-number":["75N92022D00005"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007024"],"award-info":[{"award-number":["T32HL007024"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.xkme.2023.100719","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T12:14:20Z","timestamp":1692965660000},"page":"100719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Dustin","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando M.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Schelling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph V.","family":"Bonventre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata S.","family":"Sabbisetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Schrauben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven G.","family":"Coca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey M.","family":"Rebholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10225","key":"10.1016\/j.xkme.2023.100719_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.xkme.2023.100719_bib2","series-title":"Chronic kidney disease in the United States","year":"2021"},{"issue":"4 Supplement 1","key":"10.1016\/j.xkme.2023.100719_bib3","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.02.001","article-title":"U.S. renal data system. 2021. annual data report: epidemiology of kidney disease in the United States","volume":"79","author":"Johansen","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"23","key":"10.1016\/j.xkme.2023.100719_bib4","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in Type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.xkme.2023.100719_bib5","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2023.100719_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in Patients with Chronic Kidney Disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.xkme.2023.100719_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1159\/000516213","article-title":"Effects of finerenone combined with empagliflozin in a model of hypertension-induced end-organ damage","volume":"52","author":"Kolkhof","year":"2021","journal-title":"Am J Nephrol"},{"issue":"19","key":"10.1016\/j.xkme.2023.100719_bib8","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.xkme.2023.100719_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. the diabetes control and complications (DCCT) research group","volume":"47","year":"1995","journal-title":"Kidney Int"},{"issue":"9722","key":"10.1016\/j.xkme.2023.100719_bib10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(09)62004-3","article-title":"Early recognition and prevention of chronic kidney disease","volume":"375","author":"James","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.xkme.2023.100719_bib11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ekir.2022.03.018","article-title":"Plasma biomarkers as risk factors for incident CKD","volume":"7","author":"Sarnak","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1016\/j.xkme.2023.100719_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1681\/ASN.2022010098","article-title":"Systematic review and meta-analysis of plasma and urine biomarkers for CKD outcomes","volume":"33","author":"Liu","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1681\/ASN.2011060628","article-title":"Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes","volume":"23","author":"Gohda","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2023.100719_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2215\/CJN.13631217","article-title":"Soluble urokinase-type plasminogen activator receptor in black Americans with CKD","volume":"13","author":"Luo","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ekir.2020.12.025","article-title":"The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study","volume":"6","author":"Srivastava","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.xkme.2023.100719_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1681\/ASN.2020040487","article-title":"Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) Study","volume":"32","author":"Schrauben","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100719_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1681\/ASN.2019070723","article-title":"Plasma biomarkers of tubular injury and inflammation are associated with CKD progression in children","volume":"31","author":"Greenberg","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100719_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2020.11.014","article-title":"Biomarkers of immune activation and incident kidney failure with replacement therapy: findings from the African American study of kidney disease and hypertension","volume":"78","author":"Chen","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2023.100719_bib19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.2011.283","article-title":"Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study","volume":"80","author":"Shankar","year":"2011","journal-title":"Kidney Int"},{"issue":"20","key":"10.1016\/j.xkme.2023.100719_bib20","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.xkme.2023.100719_bib21","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.jacc.2021.04.035","article-title":"The ARIC (Atherosclerosis Risk In Communities) Study: JACC focus Seminar 3\/8","volume":"77","author":"Wright","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.xkme.2023.100719_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00125-006-0497-8","article-title":"Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db\/db mice","volume":"50","author":"Chow","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.xkme.2023.100719_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1681\/ASN.2012060579","article-title":"Chitinase-like protein Brp-39\/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function","volume":"24","author":"Schmidt","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100719_bib24","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1681\/ASN.2016101101","article-title":"Plasma biomarkers and kidney function decline in early and established diabetic kidney disease","volume":"28","author":"Coca","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100719_bib25","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1681\/ASN.2013070758","article-title":"Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes","volume":"25","author":"Sabbisetti","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100719_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk In Communities (ARIC) Study: design and objectives. The ARIC investigators","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100719_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365519950185940","article-title":"Evaluation of the Dade Behring N Latex cystatin C assay on the Dade Behring Nephelometer II System","volume":"59","author":"Erlandsen","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.xkme.2023.100719_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.xkme.2023.100719_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","article-title":"Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease","volume":"145","author":"Shlipak","year":"2006","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.xkme.2023.100719_bib31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in Determining Risk Based on Kidney Function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xkme.2023.100719_bib32","unstructured":"StataCorp. Stata statistical software: release 16, 2019. StataCorp LLC. Accessed July 19, 2022. https:\/\/www.stata.com."},{"key":"10.1016\/j.xkme.2023.100719_bib33","series-title":"The R project for statistical computing. R Core Team","year":"2020"},{"key":"10.1016\/j.xkme.2023.100719_bib34","series-title":"Modern Applied Statistics With S","author":"Venables","year":"2003"},{"key":"10.1016\/j.xkme.2023.100719_bib35","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2009"},{"issue":"2","key":"10.1016\/j.xkme.2023.100719_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.08780621","article-title":"Association between TNF receptors and KIM-1 with kidney outcomes in early-stage diabetic kidney disease","volume":"17","author":"Waijer","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139927","article-title":"Biomarkers of inflammation and repair in kidney disease progression","volume":"131","author":"Puthumana","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.xkme.2023.100719_bib38","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.ajkd.2012.05.014","article-title":"Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"60","author":"Peralta","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2023.100719_bib39","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1681\/ASN.2018070719","article-title":"Association of soluble TNFR-1 concentrations with long-term decline in kidney function: the multi-ethnic study of atherosclerosis","volume":"29","author":"Bhatraju","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2023.100719_bib40","author":"Factor"},{"issue":"2","key":"10.1016\/j.xkme.2023.100719_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/gfy382","article-title":"Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years","volume":"35","author":"Schulz","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"7-8","key":"10.1016\/j.xkme.2023.100719_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00424-017-2026-7","article-title":"suPAR and chronic kidney disease-a podocyte story","volume":"469","author":"Zeier","year":"2017","journal-title":"Pflugers Arch"},{"issue":"12","key":"10.1016\/j.xkme.2023.100719_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.xkme.2023.100719_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep40627","article-title":"Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus","volume":"7","author":"Guthoff","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.xkme.2023.100719_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2015.314","article-title":"Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes","volume":"89","author":"Nowak","year":"2016","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2215\/CJN.02780319","article-title":"Urine markers of kidney tubule cell injury and kidney function decline in Sprint trial participants with CKD","volume":"15","author":"Malhotra","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100719_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000508051","article-title":"KIM-1 and kidney disease progression in autosomal dominant polycystic kidney disease: HALT-PKD results","volume":"51","author":"Griffin","year":"2020","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100719_bib48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes","volume":"87","author":"Pavkov","year":"2015","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2023.100719_bib49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2021.09.018","article-title":"Associations of plasma biomarkers of inflammation, fibrosis, and kidney tubular injury with progression of diabetic kidney disease: A cohort Study","volume":"79","author":"Guti\u00e9rrez","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"6 Pt 1","key":"10.1016\/j.xkme.2023.100719_bib50","first-page":"L399","article-title":"Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability","volume":"257","author":"Royall","year":"1989","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonz\u00e1lez","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100719_bib52","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100719_bib53","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/ajt.14284","article-title":"Urinary markers of fibrosis and risk of cardiovascular events and death in kidney transplant recipients: the FAVORIT trial","volume":"17","author":"Park","year":"2017","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2016.10.019","article-title":"Urine fibrosis markers and risk of allograft failure in kidney transplant recipients: A case-cohort ancillary study of the FAVORIT trial","volume":"69","author":"Ix","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2023.100719_bib55","article-title":"Urinary EGF and MCP-1 and risk of CKD after cardiac surgery","volume":"6","author":"Menez","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.xkme.2023.100719_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12882-018-1043-x","article-title":"Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease","volume":"19","author":"Satirapoj","year":"2018","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100719_bib57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M18-1037","article-title":"Kidney damage biomarkers and incident chronic kidney disease during blood pressure reduction: A case-control study","volume":"169","author":"Zhang","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.xkme.2023.100719_bib58","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.ekir.2021.03.893","article-title":"Enhanced MCP-1 release in early autosomal dominant polycystic kidney disease","volume":"6","author":"Janssens","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1016\/j.xkme.2023.100719_bib59","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.transproceed.2014.09.017","article-title":"YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients","volume":"46","author":"Malyszko","year":"2014","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.xkme.2023.100719_bib60","article-title":"Prognosis and reclassification by YKL-40 in stable coronary artery disease","volume":"9","author":"Schroder","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.xkme.2023.100719_bib61","first-page":"9","article-title":"A\u00a0Study of Effects of MultiCollinearity in the Multivariable Analysis","volume":"4","author":"Yoo","year":"2014","journal-title":"Int J Appl Sci Technol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ekir.2017.02.001","article-title":"Cardiovascular disease biomarkers and suPAR in predicting decline in renal function: A prospective cohort Study","volume":"2","author":"Hayek","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.xkme.2023.100719_bib63","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1681\/ASN.2021060735","article-title":"Longitudinal TNFR1 and TNFR2 and kidney outcomes: results from AASK and VA NEPHRON-D","volume":"33","author":"Chen","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100719_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ndt\/gfy265","article-title":"Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease","volume":"35","author":"Lv","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2023.100719_bib65","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.kint.2017.02.010","article-title":"Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease","volume":"92","author":"Yamanouchi","year":"2017","journal-title":"Kidney Int"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:25:22Z","timestamp":1762910722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2590059523001371"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100719","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100719"}}